Second Ustekinumab Biosimilar Gets FDA ApprovalApril 18, 2024Psoriatic ArthritisPsoriasisRheumatologyDermatologyGastroenterology
FDA OKs First-in-Class Agent for Pulmonary Arterial HypertensionMarch 28, 2024PulmonologyCardiologyHypertensionLupus & Connective Tissue Diseases
New Cancer Surgical Tech Gets Positive Vote, But Some Cite Safety ConcernsMarch 8, 2024Breast CancerPatient & Survivor CarePractice ManagementMetastatic Breast CancerPreventive CareOncologySurgical Oncology
Second FDA-Approved Tocilizumab Biosimilar Has Intravenous, Subcutaneous FormulationsMarch 8, 2024Rheumatoid ArthritisLupus & Connective Tissue DiseasesPediatricsRare DiseasesMusculoskeletal DisordersRheumatology
First Denosumab Biosimilar Approved in Two Different FormulationsMarch 6, 2024OsteoporosisOncologyRheumatologyEndocrinologyLymphoma & Plasma Cell DisordersGenitourinary CancerBreast Cancer
FDA Approves 10th Humira Biosimilar, With InterchangeabilityFebruary 27, 2024Rheumatoid ArthritisSpondyloarthropathiesAnkylosing spondylitisPsoriatic ArthritisPsoriasisPediatricsGastroenterology
Vibrating Belt Receives Approval to Help Women With Osteopenia Keep Bone StrengthJanuary 25, 2024EndocrinologyWomen's HealthRheumatologyOsteoporosis
Hypocalcemia Risk Warning Added to Osteoporosis DrugJanuary 22, 2024OsteoporosisRheumatologyNephrologyEndocrinology
FDA OKs first ustekinumab biosimilarNovember 1, 2023Psoriatic ArthritisPediatricsRare DiseasesMusculoskeletal DisordersGastroenterologyDermatologyRheumatology
FDA approves abatacept for pediatric patients with psoriatic arthritisNovember 1, 2023Psoriatic ArthritisPediatricsRheumatology
Approximately 20% of U.S. adults are diagnosed with arthritisOctober 18, 2023OsteoarthritisRheumatoid ArthritisPsoriatic ArthritisSpondyloarthropathiesAnkylosing spondylitisLupus & Connective Tissue DiseasesGout
Intravenous formulation of secukinumab gets FDA approvalOctober 10, 2023Psoriatic ArthritisSpondyloarthropathiesPediatricsAnkylosing spondylitisPsoriasisDermatologyRheumatology
FDA approves ninth Humira biosimilar, with interchangeabilityOctober 6, 2023Rheumatoid ArthritisPsoriatic ArthritisPediatricsSpondyloarthropathiesAnkylosing spondylitisRheumatologyMusculoskeletal Disorders
FDA approves first tocilizumab biosimilarOctober 3, 2023Rheumatoid ArthritisPediatricsRheumatologyRare DiseasesMusculoskeletal DisordersImmunology